Showing results (321-330 of 353) with videos related to

Sort By:
Pageof 36
Molecular Medicine (Cambridge, Mass.)|September 14, 2011
Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcomeValeria R Mas, Mariano J Scian, Kellie J Archer, et al.
Genetics, Selection, Evolution : GSE|November 8, 2008
Identification of a differentially expressed gene, ACL, between Meishan x Large White and Large White x Meishan F1 hybrids and their parentsZhu-Qing Ren, Yan Wang, Yong-Jie Xu, et al.
Natural Products and Bioprospecting|April 3, 2025
Structurally diverse polyketides and alkaloids produced by a plant-derived fungus Penicillium canescens L1Wei-Ye Wu, Xun Wei, Qiong Liao, et al.
Plos Genetics|March 29, 2008
Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese populationXing Fan, Sen Yang, Wei Huang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 12, 2025
[Medication rules of Astragali Radix in ancient Chinese medical books based on "disease-medicine-dose" pattern]Jia-Lei Cao, Lü-Yuan Liang, Yi-Hang Liu, et al.
Expert Opinion on Biological Therapy|October 5, 2021
A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjectsGuangwen Liu, Zhongnan Xu, Wei Yang, et al.
Archives of Dermatological Research|March 23, 2006
Five mutations of ATP2A2 gene in Chinese patients with Darier's disease and a literature review of 86 cases reported in ChinaYun-Qing Ren, Min Gao, Yan-Hua Liang, et al.
Expert Opinion on Investigational Drugs|February 9, 2023
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjectsYanli Wang, Jinling Xue, Zhengjie Su, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 12, 2022
A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjectsZhengzhi Liu, Zhenyue Gao, Wei Yang, et al.
Phytochemical Analysis : PCA|November 21, 2024
A Biolayer Interferometry-Based SARS-COV-2 Mpro-Targeted Active Ingredients Recognition System: Construction and Application in Ligand Screening From Herbal MedicinesDai Zhang, Bing Han, Xiao-Fei Chen, et al.
Pageof 36